Release Date: 19/09/12 16:29 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 25.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%